tiprankstipranks
Trending News
More News >
Kissei Pharmaceutical Co Ltd (JP:4547)
:4547
Japanese Market
Advertisement

Kissei Pharmaceutical Co (4547) Ratios

Compare
0 Followers

Kissei Pharmaceutical Co Ratios

JP:4547's free cash flow for Q3 2024 was ¥0.51. For the 2024 fiscal year, JP:4547's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
6.45 5.92 6.73 5.30 5.10
Quick Ratio
4.95 4.43 5.20 4.29 3.99
Cash Ratio
1.52 1.30 1.73 1.60 1.12
Solvency Ratio
0.49 0.39 0.55 0.46 0.17
Operating Cash Flow Ratio
0.00 -0.09 -0.45 0.08 -0.14
Short-Term Operating Cash Flow Coverage
0.00 -1.25 -4.48 0.93 -1.46
Net Current Asset Value
¥ 73.05B¥ 64.76B¥ 74.25B¥ 63.43B¥ 44.06B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.17 1.19 1.14 1.18 1.23
Debt Service Coverage Ratio
12.88 11.46 9.78 10.09 4.84
Interest Coverage Ratio
577.50 223.17 -56.45 -60.96 65.43
Debt to Market Cap
<0.01 <0.01 0.01 0.01 0.02
Interest Debt Per Share
30.14 30.01 32.74 36.06 37.84
Net Debt to EBITDA
-1.18 -1.15 -1.37 -1.40 -1.76
Profitability Margins
Gross Profit Margin
49.89%49.41%47.97%47.78%47.39%
EBIT Margin
17.70%19.14%20.30%25.28%10.86%
EBITDA Margin
22.93%24.77%26.38%30.99%15.42%
Operating Profit Margin
6.54%5.31%-1.67%-2.14%2.18%
Pretax Profit Margin
17.67%19.12%20.27%25.25%10.83%
Net Profit Margin
13.54%14.77%15.60%19.76%7.65%
Continuous Operations Profit Margin
13.56%14.94%15.76%19.93%7.79%
Net Income Per EBT
76.63%77.24%76.96%78.28%70.69%
EBT Per EBIT
270.27%359.70%-1211.69%-1177.39%496.74%
Return on Assets (ROA)
4.90%4.28%4.76%5.43%1.97%
Return on Equity (ROE)
5.57%5.07%5.43%6.42%2.41%
Return on Capital Employed (ROCE)
2.54%1.65%-0.55%-0.64%0.60%
Return on Invested Capital (ROIC)
1.94%1.28%-0.42%-0.50%0.43%
Return on Tangible Assets
4.94%4.31%4.79%5.46%1.98%
Earnings Yield
6.68%7.12%8.64%10.97%4.62%
Efficiency Ratios
Receivables Turnover
2.98 2.64 3.06 2.98 2.99
Payables Turnover
9.62 7.81 7.61 8.32 4.59
Inventory Turnover
1.77 1.45 1.54 1.80 1.81
Fixed Asset Turnover
3.26 3.04 2.75 2.72 2.84
Asset Turnover
0.36 0.29 0.31 0.27 0.26
Working Capital Turnover Ratio
1.00 0.88 0.81 0.84 0.89
Cash Conversion Cycle
290.56 342.80 308.39 281.68 244.59
Days of Sales Outstanding
122.53 138.50 119.42 122.57 121.90
Days of Inventory Outstanding
205.97 251.01 236.95 202.98 202.17
Days of Payables Outstanding
37.95 46.71 47.99 43.87 79.48
Operating Cycle
328.50 389.51 356.38 325.55 324.07
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -37.05 -144.83 33.24 -54.47
Free Cash Flow Per Share
0.00 -77.55 -200.07 -8.37 -86.29
CapEx Per Share
0.00 40.50 55.23 41.61 31.82
Free Cash Flow to Operating Cash Flow
0.00 2.09 1.38 -0.25 1.58
Dividend Paid and CapEx Coverage Ratio
0.00 -0.30 -1.18 0.34 -0.64
Capital Expenditure Coverage Ratio
0.00 -0.91 -2.62 0.80 -1.71
Operating Cash Flow Coverage Ratio
0.00 -1.25 -4.48 0.93 -1.46
Operating Cash Flow to Sales Ratio
0.00 -0.02 -0.10 0.02 -0.04
Free Cash Flow Yield
0.00%-2.24%-7.58%-0.33%-3.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.76 14.05 11.57 9.12 21.63
Price-to-Sales (P/S) Ratio
1.94 2.07 1.80 1.80 1.66
Price-to-Book (P/B) Ratio
0.84 0.71 0.63 0.59 0.52
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -44.68 -13.20 -305.24 -28.39
Price-to-Operating Cash Flow Ratio
0.00 -93.51 -18.23 76.86 -44.98
Price-to-Earnings Growth (PEG) Ratio
4.30 1.75 -0.62 0.06 0.25
Price-to-Fair Value
0.84 0.71 0.63 0.59 0.52
Enterprise Value Multiple
7.26 7.23 5.47 4.41 8.98
Enterprise Value
149.52B 135.27B 97.39B 89.45B 95.62B
EV to EBITDA
7.38 7.23 5.47 4.41 8.98
EV to Sales
1.69 1.79 1.44 1.37 1.38
EV to Free Cash Flow
0.00 -38.54 -10.56 -231.74 -23.74
EV to Operating Cash Flow
0.00 -80.66 -14.58 58.35 -37.62
Tangible Book Value Per Share
4.86K 4.84K 4.19K 4.35K 4.68K
Shareholders’ Equity Per Share
4.88K 4.86K 4.20K 4.37K 4.70K
Tax and Other Ratios
Effective Tax Rate
0.23 0.22 0.22 0.21 0.28
Revenue Per Share
2.06K 1.67K 1.46K 1.42K 1.48K
Net Income Per Share
279.43 246.58 228.30 280.19 113.25
Tax Burden
0.77 0.77 0.77 0.78 0.71
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.08 0.13 0.15 0.16 0.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 -0.15 -0.49 0.09 -0.34
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis